Gapping up
In reaction to strong earnings/guidance:
- SERV +0.6% (guidance)
M&A news:
- GRUB +10.8% (Just Eat Takeaway.com to acquire GrubHub $75.15/share in all-stock deal - CNBC)
Other news:
- SRNE +10.4% (submits Emergency Use Authorization application for the COVI-TRACK diagnostic test)
- RETA +7.5% (Reata Pharmaceuticals and Blackstone Life Sciences (BX) announce $350 million strategic investment)
- ZYXI +7% (to join S&P SmallCap 600)
- PFSI +3.2% (approves repurchase of 6,975,323 shares from BlackRock Foundation at $34/sh)
- JACK +3.1% (provides update; says comps accelerated into JunQ)
- PSTI +2.7% (announced the activation of clinical sites and initiation of enrollment in its Phase II U.S. Food and Drug Administration (FDA) study of PLX cells for the treatment of severe COVID-19 complicated by Acute Respiratory Distress Syndrome)
- REGN +2.5% (publication of two papers in Science describing the creation of its novel two-antibody cocktail, REGN-COV2, and announces that REGN-COV2 has entered human clinical trials)
- PSNL +2.4% (partners with Berry Genomics for expansion in China)
- UN +1.8% (announced plans to unify its Group legal structure under a single parent company, Unilever PLC, creating a simpler company with greater strategic flexibility)
- BNTX +1.2% (receives €100 mln in debt financing for COVID-19 vaccine development and manufacturing)
- PRIM +1.2% (announces three new utility awards valued over $45 mln)
Analyst comments:
- SWAV +0.5% (upgraded to Perform from Underperform at Oppenheimer)